NCT07579845 Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress
| NCT ID | NCT07579845 |
| Status | Recruiting |
| Phase | — |
| Sponsor | OvationLab |
| Condition | Detoxification |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-05-05 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-05-05 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.
Eligibility Criteria
Inclusion Criteria: 1. Adult females or males age ≥ 40 years 2. Ability to read and speak English Exclusion Criteria: 1. Current use of a dietary supplement containing fulvic or humic acid 2. Current use of other binder dietary supplements, including activated charcoal, modified citrus pectin, bentonite clay, or chlorella 3. Known allergies to any ingredients in the product 4. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks 5. Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol 6. Participants unable to provide consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07579845 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Detoxification. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07579845 currently recruiting?
Yes, NCT07579845 is actively recruiting participants. Contact the research team at info@ovationlab.com for enrollment information.
Where is the NCT07579845 trial being conducted?
This trial is being conducted at Richmond, United States.
Who is sponsoring the NCT07579845 clinical trial?
NCT07579845 is sponsored by OvationLab. The trial plans to enroll 60 participants.